Back
NovaBay Pharmaceuticals, Inc. Vs. Eli Lilly & Co. Industry Stock Comparison
Buy
85
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$10.57
Seasonality Move:
13.91%
Buy
84
LLY
Eli Lilly & Co.
Last Price:
$1,108.12
Seasonality Move:
2.33%
Buy
85
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $10.64. The Score for NBY is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
84
Eli Lilly & Co. (LLY)
is a Buy
Is Eli Lilly & Co. a Buy, Sell or Hold?
-
The current Eli Lilly & Co. [LLY] share price is $1,108.09. The Score for LLY is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $10.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly & Co.'s stock price today?
-
The Eli Lilly & Co. share price today is $1,108.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.65 | Buy |
| Relative Strength Index (14 RSI): | 86.71 | Buy |
| Chaikin Money Flow: | 2519680 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.47 - 6.17) | Buy |
| Bollinger Bands (100): | (0.39 - 3.73) | Buy |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 19.66 | Buy |
| Relative Strength Index (14 RSI): | 64.95 | Buy |
| Chaikin Money Flow: | 2517187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1016.96 - 1081.56) | Buy |
| Bollinger Bands (100): | (751.63 - 1028.53) | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.39 | Buy |
| 20-day SMA: | 4.5 | Buy |
| 50-day SMA: | 2.45 | Buy |
| 200-day SMA: | 1.33 | Buy |
| 8-day EMA: | 6.9 | Buy |
| 20-day EMA: | 5.01 | Buy |
| 50-day EMA: | 3.15 | Buy |
| 200-day EMA: | 1.18 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1075.61 | Buy |
| 20-day SMA: | 1056.47 | Buy |
| 50-day SMA: | 1012.66 | Buy |
| 200-day SMA: | 831.54 | Buy |
| 8-day EMA: | 1075.29 | Buy |
| 20-day EMA: | 1060.47 | Buy |
| 50-day EMA: | 1006.39 | Buy |
| 200-day EMA: | 875.53 | Buy |
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Eli Lilly & Co. Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.97 per share, and an increase next year of $7.50 per share.
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly & Co. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||